3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
44
Colonic Neoplasms
17
Colonic Polyps
12
Adenoma
8
Polyps
4
Gastrointestinal Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Adenomatous Polyps
3
Rectal Neoplasms
2
Neoplasms
2
Intestinal Neoplasms
2
Stomach Neoplasms
1
Rectal Diseases
1
Peptic Ulcer
1
Patient Satisfaction
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Metabolic Syndrome
1
Liver Cirrhosis
1
Irritable Bowel Syndrome
1
Intestinal Diseases
1
Hyperplasia
1
Gastrointestinal Hemorrhage
1
Gastrointestinal Diseases
1
Gastritis, Atrophic
1
Diverticulitis, Colonic
1
Diverticulitis
1
Disease
1
Interventions
trimebutine 3-thiocarbamoylbenzenesulfonate
2
pembrolizumab
2
Oxaliplatin
2
Cyclophosphamide
2
pralsetinib
1
napabucasin
1
ibrutinib
1
guadecitabine
1
XELOX
1
Sutures
1
Surgical Instruments
1
Polyethylene Glycols
1
Optical Imaging
1
Ocoxin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Control Groups
1
Colonoscopy
1
Cetuximab
1
Capecitabine
1
Bevacizumab
1
Ascorbic Acid
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colonic Diseases
×
Colonoscopy
×
Clear all
NCT04287335
2020-12-08
CLEAR-C
Zhejiang University
Completed
4,758 enrolled